Simon Husby

Simon Husby

Senior Researcher


  1. 2023
  2. Published

    CD3xCD20 Bispecific Antibodies Yields Long-Term Survival in Relapsed/Refractory B Cell Lymphoma: A Follow-up Study of Patients Treated in Pivotal Phase 1/2 Trials

    Kyvsgaard, Emil Ramsø, Clausen, M. R., Hasselbalch Riley, A. C., Niemann, Carsten, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 28 Nov 2023, In: Blood. 142, Supplement 1, p. 618-618

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Immunohistochemical Tumor Expression Predicts Response to CD3xCD20 Bispecific Antibodies in Patients with Relapsed/Refractory B Cell Lymphoma

    Kyvsgaard, Emil Ramsø, Clausen, M. R., Hasselbalch Riley, A. C., Niemann, Carsten, Sjö, Lene Dissing, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 28 Nov 2023, In: Blood. 142, Supplement 1, p. 6113-6113

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score

    Salim, Ruth, Husby, Simon, Winther Eskelund, C., Scott, D. W., Holte, H., Kolstad, A., Räty, R., Ek, S., Jerkeman, M., Geisler, C., Sommer Kristensen, L., Dahl, M. & Grønbæk, Kirsten, 2023, In: Leukemia and Lymphoma. 64, 8, p. 1414-1423

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established high-risk factors

    Gerdtsson, A. S., de Matos Rodrigues, J., Eskelund, C. W., Husby, Simon, Grønbæk, Kirsten, Räty, R., Kolstad, A., Geisler, C., Porwit, A., Jerkeman, M. & Ek, S., 2023, In: Haematologica. 108, 4, p. 1092-1104 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 19204297